Methylphenidate (Inspirion)

N/A

Report date: 2025/04/20 20:00:03
NME

Base Information

Drug NameMethylphenidate (Inspirion)
Drug Alias NameAbuse Deterrent Methylphenidate (Inspirion)methylphenidate
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors alpha-2 modulators
TargetsAdrenergic receptors alpha-2
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityFatigueBrain Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesDenmark
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesInspirion Delivery Sciences
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Southern Denmark
Inactive CompaniesInspirion Delivery Sciences
Active IndicationsFatigueBrain Neoplasms
Inactive IndicationsAttention Deficit Disorder with Hyperactivity

Other Information

ATC CodeN/A
Related LinksN/A